Sanofi · SNY · Next earnings

Sanofi reports Thursday, Feb 4, 2027

SNY reports before market open with consensus EPS at $1.07 and revenue at $14.38B. Last quarter: Sanofi lifts 2026 outlook as Dupixent and launches drive Q3 growth

Reports Before market open94 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $1.07 Calendar consensus
Consensus revenue $14.38B Calendar consensus
Report date Feb 4, 2027 Thursday, date estimated
Session Before market open 94 days away

Where SNY left off: FY2026 Q3

Full report

Sanofi lifts 2026 outlook as Dupixent and launches drive Q3 growth

EPS surprise +30.8% Reported $2.04 vs $1.56
Revenue surprise +14.4% Reported $16.36B vs $14.30B
Stock move +2.8% Event window
Subsequent drift +1.5% Up to 20 sessions

Raised 2026 guidance to 13–15% sales growth and 15–17% EPS growth, according to the Q3 call analysis; the prior-quarter analysis cited approximately 10% full-year sales growth.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Dupixent loss of exclusivity could pressure revenue and margins.
  • US pricing and gross-to-net adjustments, including 340B-related uncertainty, may affect reported growth.
  • Pipeline timelines, regulatory outcomes and the execution of the R&D and partnership strategy remain uncertain.

Questions analysts left open

  • How Dupixent loss of exclusivity may affect volume and pricing in 2027.
  • Whether future business development and M&A activity will be sufficient and appropriately timed.
  • The R&D spending trajectory and delivery against regulatory and clinical timelines for key assets.

Ask FN2 about SNY next report

Transcript, numbers and history already loaded
What should I watch for in SNY's next earnings report?How did SNY guide last quarter, and is consensus above or below that?Give me the bull and bear case going into SNY earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the SNY recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent SNY quarters

All SNY earnings
+2.8%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.